Cardlytics (CDLX) EPS (Weighted Average and Diluted) (2017 - 2025)
Historic EPS (Weighted Average and Diluted) for Cardlytics (CDLX) over the last 8 years, with Q3 2025 value amounting to -$1.36.
- Cardlytics' EPS (Weighted Average and Diluted) rose 5310.34% to -$1.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.05, marking a year-over-year increase of 6740.86%. This contributed to the annual value of -$3.91 for FY2024, which is 608.11% down from last year.
- Cardlytics' EPS (Weighted Average and Diluted) amounted to -$1.36 in Q3 2025, which was up 5310.34% from -$0.18 recorded in Q2 2025.
- Cardlytics' 5-year EPS (Weighted Average and Diluted) high stood at $0.91 for Q1 2022, and its period low was -$11.32 during Q4 2022.
- Over the past 5 years, Cardlytics' median EPS (Weighted Average and Diluted) value was -$0.65 (recorded in 2023), while the average stood at -$1.5.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 20705.88% in 2022, then tumbled by 43631.16% in 2023.
- Quarter analysis of 5 years shows Cardlytics' EPS (Weighted Average and Diluted) stood at -$1.35 in 2021, then crashed by 738.52% to -$11.32 in 2022, then skyrocketed by 75.8% to -$2.74 in 2023, then soared by 88.24% to -$0.32 in 2024, then plummeted by 321.91% to -$1.36 in 2025.
- Its last three reported values are -$1.36 in Q3 2025, -$0.18 for Q2 2025, and -$0.26 during Q1 2025.